Taken together, preclinical and clinical studies have demonstrated that GLP-1 receptor agonists exert pleiotropic effects extending beyond glycemic control, influencing multiple organ systems including the nervous, respiratory, hepatic, renal, cardiovascular, reproductive, and immune systems (Figure 4)
En el contexto de la estimulacin de la secrecin de insulina, la unin de los anlogos al receptor de GLP-1 activa la adenilato ciclasa, generando as un aumento en la concentracin intracelular de adenosn monofosfato cclico (AMPc)
The results showed that tirzepatide, at all doses, achieved superior reductions in HbA1c compared to insulin degludec at week 52, meeting the non-inferiority criteria
These cases are often designed for insulin but work perfectly for semaglutide pens
Clinical Study Results Our numbers don't lie